Maplelane Capital’s Celestica CLS Stock Holding History

Maplelane Capital’s Portfolio CLS Stock Details CLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26.8M	Buy	+37,976	New	+$11M	0.96%	36

Other funds holding CLS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

WRCM

Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return

Maplelane Capital's CLS Position: Q1 2026 in Review

Maplelane Capital opened a new position in Celestica (CLS) in Q1 2026: 111,000 shares worth $31.3M. The stake represents 1.12% of the portfolio and ranks #33 among its holdings.

773 funds tracked by Wall St. Rank hold CLS as of Q1 2026.

Maplelane Capital held 111,000 shares of Celestica worth $31.3M as of Q1 2026.
Celestica was a new Maplelane Capital position in Q1 2026.
Celestica made up 1.12% of Maplelane Capital's portfolio in Q1 2026, its #33 holding.
773 funds tracked by Wall St. Rank held Celestica as of Q1 2026.

Based on Maplelane Capital's 13F filing for Q1 2026, filed 14 May 2026.